Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 13/20 | 0.35 |
| ▸ | SCN5A | Q14524 | 12/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 11/20 | 0.35 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | GHSR | Q92847 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL840895 | 0.99 | SCN9A (0.36) | SCN9ASCN5AKCNH2DHFRSLC6A3 | |
| Ammonia Solution, Strong SCHEMBL3672811 | 0.86 | SCN9A (0.46) | SCN9ASCN5AKCNH2SLC6A3GHSR | |
| SCHEMBL839850 | 0.84 | SCN9A (0.46) | SCN9ASCN5AKCNH2SLC6A3GHSR | |
| Ammonia Solution, Strong SCHEMBL3673794 | 0.82 | SCN9A (0.38) | SCN9ASCN5AKCNH2DHFRSLC6A3 | |
| Ammonia Solution, Strong SCHEMBL3668899 | 0.82 | SCN9A (0.49) | SCN9ASCN5AKCNH2SLC6A3GHSR | |
| SCHEMBL841245 | 0.81 | SCN9A (0.43) | SCN9ASCN5AKCNH2 | |
| SCHEMBL841025 | 0.81 | SCN9A (0.49) | SCN9ASCN5AKCNH2SLC6A3GHSR | |
| SCHEMBL840902 | 0.81 | SCN9A (0.38) | SCN9ASCN5AKCNH2DHFRSLC6A3 | |
| SCHEMBL841223 | 0.80 | SCN5A (0.38) | SCN9ASCN5AKCNH2SLC6A3GHSR | |
| SCHEMBL3672940 | 0.80 | DHFR (0.33) | DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2158198-A2 | NOVEL N- (8HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | AstraZeneca AB (SE) | 2010-03-03 | — | — | EP | disclosed |
| WO-2008130320-A2 | NOVEL N- (8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | ASTRAZENECA AB (SE) | 2008-10-30 | — | — | WO | disclosed |